Composition
- Active ingredients
- BREXANOLONE 100MG/20ML (5MG/ML)
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA211371.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Zulresso
- Active substance
- brexanolone
- Drug class
- Other antidepressants
- Group
- Antidepressants
- Route
- Intravenous
- Dosage form
- Solution
- Applicant
- Sage Therap
- Status
- Discontinued
- FDA approval
- 19 Mar 2019